Abstract |
Although a well-known recommended treatment option, there are currently no studies that describe the detailed regimen of isotretinoin for the treatment of primary keratosis pilaris. Based on previous studies involving other hyperkeratotic disorders, this report describes a safe and effective treatment course of isotretinoin for severe keratosis pilaris.
|
Authors | A Kirchner, S Hoyer |
Journal | Clinical and experimental dermatology
(Clin Exp Dermatol)
Vol. 47
Issue 3
Pg. 619-621
(Mar 2022)
ISSN: 1365-2230 [Electronic] England |
PMID | 34780085
(Publication Type: Case Reports, Letter)
|
Copyright | © 2021 British Association of Dermatologists. |
Chemical References |
- Dermatologic Agents
- Isotretinoin
|
Topics |
- Abnormalities, Multiple
(drug therapy, pathology)
- Adolescent
- Darier Disease
(drug therapy, pathology)
- Dermatologic Agents
(administration & dosage, therapeutic use)
- Drug Administration Schedule
- Eyebrows
(abnormalities, pathology)
- Female
- Humans
- Isotretinoin
(administration & dosage, therapeutic use)
- Treatment Outcome
|